NDC 69597-348

ASPIRIN/OMEPRAZOLE

Aspirin And Omeprazole

ASPIRIN/OMEPRAZOLE is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Basiem. The primary component is Aspirin; Omeprazole.

Product ID69597-348_bef20e05-a18c-4d1f-96ce-e13072ffeebd
NDC69597-348
Product TypeHuman Prescription Drug
Proprietary NameASPIRIN/OMEPRAZOLE
Generic NameAspirin And Omeprazole
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-04-10
Marketing CategoryNDA / NDA
Application NumberNDA205103
Labeler NameBasiem
Substance NameASPIRIN; OMEPRAZOLE
Active Ingredient Strength81 mg/1; mg/1
Pharm ClassesCyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 69597-348-15

15 TABLET, FILM COATED in 1 BOTTLE (69597-348-15)
Marketing Start Date2019-04-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69597-348-15 [69597034815]

ASPIRIN/OMEPRAZOLE TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA205103
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-04-10
Marketing End Date2019-04-28

Drug Details

Active Ingredients

IngredientStrength
ASPIRIN81 mg/1

OpenFDA Data

SPL SET ID:603511cf-f9f6-4a7f-8885-34c5978b9677
Manufacturer
UNII
Pharm Class PE
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
  • PHarm Class EPC
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
  • UPC Code
  • 0369597348156
  • NUI Code
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722
  • Pharmacological Class

    • Cyclooxygenase Inhibitors [MoA]
    • Decreased Prostaglandin Production [PE]
    • Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
    • Nonsteroidal Anti-inflammatory Drug [EPC]
    • Platelet Aggregation Inhibitor [EPC]
    • Decreased Platelet Aggregation [PE]
    • Proton Pump Inhibitor [EPC]
    • Proton Pump Inhibitors [MoA]
    • Cytochrome P450 2C19 Inhibitors [MoA]

    NDC Crossover Matching brand name "ASPIRIN/OMEPRAZOLE" or generic name "Aspirin And Omeprazole"

    NDCBrand NameGeneric Name
    69597-348ASPIRIN/OMEPRAZOLEaspirin and omeprazole
    71800-014aspirin and omeprazole delayed-release tabaspirin and omeprazole
    71800-018aspirin and omeprazole delayed-release tabaspirin and omeprazole
    73457-415aspirin and omeprazole delayed-release tabaspirin and omeprazole
    64950-424Yospralaaspirin and omeprazole
    64950-425Yospralaaspirin and omeprazole
    70347-081YOSPRALAAspirin and Omeprazole
    70347-325YOSPRALAAspirin and Omeprazole
    71800-012Yospralaaspirin and omeprazole
    71800-016Yospralaaspirin and omeprazole
    73568-004Yospralaaspirin and omeprazole
    73568-005Yospralaaspirin and omeprazole

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.